The FDA has granted Breakthrough Therapy designation to BPL-003 (mebufotenin benzoate) nasal spray for adults with treatment-resistant depression.

The neurodegenerative disease damages patients' motor, cognitive and behavioral controls, which sometimes manifest as ...

Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point ...

Moment of Clarity has announced the introduction of ketamine therapy for its Long Beach facility, expanding the range of outpatient treatment options available for individuals struggling with ...

Moment of Clarity has announced the launch of Ketamine therapy at its outpatient mental health center, expanding treatment options for individuals struggling with depression and related conditions.

Have you noticed you're sleeping a little longer? Maybe you're experiencing a shift in appetite — craving more sweets or pasta. In autumn, our bodies sense the change in light as the dark winter ...

•Innovative Care: Humber will be one of the first Ontario hospitals to offer repetitive transcranial magnetic stimulation (rTMS) via direct primary care referral, providing a noninvasive treatment for ...

COLUMBUS, Ohio (WCMH) — An Ohio State University study has revealed that psychedelic-assisted therapy might have long-term benefits for people suffering from depression. The results were published ...

Houston police are investigating after a man was shot by security during a confrontation at a Houston water treatment facility on Friday morning. The incident happened around 9 a.m. at the facility ...

Major depressive disorder (MDD) is a multifactorial condition shaped by neurobiological, psychological, and environmental influences. Recent evidence highlights the gut–brain axis (GBA), a ...

A new study led by Mass General Brigham investigators compared the effects of repeated intravenous (IV) ketamine and intranasal (IN) esketamine in patients with treatment-resistant depression. In a ...